ClinicalTrials.Veeva

Menu

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

A

Armed Forces Institute of Urology, Rawalpindi

Status and phase

Completed
Phase 1

Conditions

Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi

Treatments

Drug: Tamsulosin
Drug: Silodosin

Study type

Interventional

Funder types

Other

Identifiers

NCT05790902
AFIU-2022-02

Details and patient eligibility

About

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.

Full description

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and quickly cures the disease thus enabling the person to return to routine activity with less adverse effects.

Enrollment

142 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • symptomatic, unilateral, single, uncomplicated Distal Ureteric Calculi of <10 mm in size (on plain CT KUB)

Exclusion criteria

  • solitary kidney, bilateral ureteric stones, UTI, renal impairment, high-grade hydronephrosis (Grades 3 and 4), any history of previous endoscopic or surgical interventions, pregnancy, diabetes mellitus,

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

142 participants in 2 patient groups

Silodosin Group
Experimental group
Description:
The patients used Silodosin for ureteric calculi
Treatment:
Drug: Silodosin
Tamsulosin Group
Experimental group
Description:
The patients used Tamsulosin for ureteric calculi
Treatment:
Drug: Tamsulosin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems